Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
that enhance public understanding of quantum science and technology, fostering engagement with educators, students, community groups, policymakers, and other stakeholders, and supporting the Centre’s strategic
-
technology development project in which UCC collaborates with two companies, Danalto and Qorvo. The UCC part of the project focuses on the development of agentic AI and digital twin concepts for Ultra-Wideband
-
8 Jul 2026 Job Information Organisation/Company University College Dublin Research Field Engineering » Chemical engineering Engineering » Chemical engineering Researcher Profile First Stage
-
implementation of pharmacogenomics and multiomics in clinical practice. The role will focus on conducting a comprehensive Health Technology Assessment (HTA), synthesising evidence on clinical effectiveness and
-
21 Months Fixed Term, Whole-time Post The researcher will be employed on a technology development project in which UCC collaborates with two companies, Danalto and Qorvo. The UCC part of the project
-
://www.aplitrak.com/?adid=YXN0cmFjemVrLjQ2NDI4Ljk5MDhAdW5pY2R1Ymxpbi5hcGxp… Requirements Skills/Qualifications Research, Administrative, Communication Additional Information Website for additional job details https
-
. NourishMind is developing novel microbiota-based product(s) for weight maintenance. The technology is supported by a growing body of preclinical and clinical evidence, protected intellectual property, and a
-
an Events and Communications Manager to support the establishment of its new research centre in Quantum Information Science and Technology, Rinn Quantum. Funded by Research Ireland, Rinn Quantum brings
-
technology, alongside local ecological knowledge, genetic sampling, sonography, blood sampling and hormone analysis, underwater video, and autonomous underwater vehicles. The successful candidate will support
-
on conducting a comprehensive Health Technology Assessment (HTA), synthesising evidence on clinical effectiveness and safety, pharmacoeconomic and cost-effectiveness outcomes, budget impact, organisational and